[
  {
    "ts": null,
    "headline": "Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?",
    "summary": "Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.",
    "url": "https://finnhub.io/api/news?id=4cf84c3f876a5d6fa2670d1527b8a7fc38a198321a996917461fd441063f0142",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734735495,
      "headline": "Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?",
      "id": 132082189,
      "image": "",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.",
      "url": "https://finnhub.io/api/news?id=4cf84c3f876a5d6fa2670d1527b8a7fc38a198321a996917461fd441063f0142"
    }
  },
  {
    "ts": null,
    "headline": "4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025",
    "summary": "Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025.",
    "url": "https://finnhub.io/api/news?id=9c4cb2a363db72d938601d8b78b94c659c48bfce00f602a795edc8c10fa24f2b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734704580,
      "headline": "4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025",
      "id": 132078710,
      "image": "https://media.zenfs.com/en/zacks.com/9a2e9cd37a84851828a28a7545d22973",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025.",
      "url": "https://finnhub.io/api/news?id=9c4cb2a363db72d938601d8b78b94c659c48bfce00f602a795edc8c10fa24f2b"
    }
  }
]